Literature DB >> 19043128

One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics.

H Winkler1, A Stoiber, K Kaudela, F Winter, F Menschik.   

Abstract

Infection of a total hip replacement (THR) requires component removal and thorough local debridement. Usually, long-term antibiotic treatment in conjunction with a two-stage revision is required. This may take several months. One-stage revision using antibiotic-loaded cement has not gained widespread use, although the clinical and economic advantages are obvious. Allograft bone may be impregnated with high levels of antibiotics, and in revision of infected THR, act as a carrier providing a sustained high local concentration. We performed 37 one-stage revision of infected THRs, without the use of cement. There were three hips which required further revision because of recurrent infection, the remaining 34 hips (92%) stayed free from infection and stable at a mean follow-up of 4.4 years (2 to 8). No adverse effects were identified. Incorporation of bone graft was comparable with unimpregnated grafts. Antibiotic-impregnated allograft bone may enable reconstruction of bone stock, insertion of an uncemented implant and control of infection in a single operation in revision THR for infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19043128     DOI: 10.1302/0301-620X.90B12.20742

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  46 in total

Review 1.  Infection in total hip replacement: meta-analysis.

Authors:  Surendra Senthi; Jacob T Munro; Rocco P Pitto
Journal:  Int Orthop       Date:  2010-11-18       Impact factor: 3.075

Review 2.  Single- or two-stage revision for infected total hip arthroplasty? A systematic review of the literature.

Authors:  Hugh A C Leonard; Alexander D Liddle; Orlaith Burke; David W Murray; Hemant Pandit
Journal:  Clin Orthop Relat Res       Date:  2013-09-21       Impact factor: 4.176

3.  Polymer-controlled release of tobramycin from bone graft void filler.

Authors:  Amanda E Brooks; Benjamin D Brooks; Sherry N Davidoff; Paul C Hogrebe; Mark A Fisher; David W Grainger
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

Review 4.  The Role of One-Stage Exchange for Prosthetic Joint Infection.

Authors:  Fiachra E Rowan; Matthew J Donaldson; Jurek R Pietrzak; Fares S Haddad
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

5.  Prevention of surgical site infections in bone and joint procedures.

Authors:  Ralf-Peter Vonberg; Petra Gastmeier
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

6.  Prosthetic joint infection following total hip replacement: results of one-stage versus two-stage exchange.

Authors:  Matthias Wolf; Heimo Clar; Jörg Friesenbichler; Gerold Schwantzer; Gerwin Bernhardt; Gerald Gruber; Mathias Glehr; Andreas Leithner; Patrick Sadoghi
Journal:  Int Orthop       Date:  2014-03-18       Impact factor: 3.075

7.  Routine one-stage exchange for chronic infection after total hip replacement.

Authors:  Jean-Yves Jenny; Régis Lengert; Yann Diesinger; Jeannot Gaudias; Cyril Boeri; Jean-François Kempf
Journal:  Int Orthop       Date:  2014-07-31       Impact factor: 3.075

8.  Vancomycin and tobramycin impregnated mineralized allograft for the surgical regenerative treatment of peri-implantitis: a 1-year follow-up case series.

Authors:  José Nart; Beatriz de Tapia; Àngels Pujol; Andrés Pascual; Cristina Valles
Journal:  Clin Oral Investig       Date:  2017-12-24       Impact factor: 3.573

Review 9.  Revision of late periprosthetic infections of total hip endoprostheses: pros and cons of different concepts.

Authors:  Bernd Fink
Journal:  Int J Med Sci       Date:  2009-09-04       Impact factor: 3.738

Review 10.  Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft.

Authors:  Heinz Winkler
Journal:  Int J Med Sci       Date:  2009-09-04       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.